Finland· FI-REL-REL51204
Bevespi Aerosphere
A formoterol und glycopyrronium bromid product containing glycopyrronium bromide + formoterol fumarate dihydrate, registered in Finland by AstraZeneca AB. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Formoterol und glycopyrronium bromid is registered in 9 of 19 countries.
Countries holding a registration under ATC R03AL07 (formoterol und glycopyrronium bromid), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Formoterol und glycopyrronium bromid · ATC R03AL07
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Glycopyrronium bromide + Formoterol fumarate dihydrate
- Manufacturer
- AstraZeneca AB
- Country
- Finland (FI)
- ATC code
- R03AL07
- ATC class
- Formoterol und Glycopyrronium bromid
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol und glycopyrronium bromid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEVESPI AEROSPHEREAstraZeneca AB, Södertälje
- United KingdomBevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhalerAstraZeneca UK Ltd
- NorwayBevespi AerosphereAstraZeneca AB (2)
- SwedenBevespi Aerosphere 7,2 mikrogram/5 mikrogram Inhalationsspray, suspensionAstraZeneca AB
- United StatesBEVESPI AEROSPHEREAstraZeneca Pharmaceuticals LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bevespi Aerosphere
- Liechtenstein · Bevespi Aerosphere
- Norway · Bevespi Aerosphere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9fa9d03a-c966-40d3-b0b3-2c22f139190f GET /v1/drugs/9fa9d03a-c966-40d3-b0b3-2c22f139190f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "4",
"form": "inhalaatiosumute, suspensio",
"route": "Inhalaatioon",
"ddd_unit": "ED",
"strength": "7.2 mikrog / 5 mikrog",
"atc_label": "formoteroli ja glykopyrroniumbromidi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/18/1339/001-002",
"fimea_rel_id": "REL51204",
"authorised_at": "2018-12-18"
}See everything about formoterol und glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.